The 340B Drug Pricing Program is a game changer for federally qualified health centers (FQHCs), which have limited flexible funding streams at their disposal and often use their 340B savings for services that are non-reimbursable. The financial impact of these savings cannot be overstated, as they allow FQHCs to stretch their already scarce federal resources […]